Rybelsus contains semaglutide, which belongs to a class of medicines called GLP-1 receptor agonists. It works by controlling blood sugar levels, slowing down digestion, and reducing appetite. It contains Semaglutide, the same active ingredient found in the injection version of Ozempic & Wegovy.
The pills are made by Novo Nordisk, the Danish pharmaceutical company behind Wegovy, Ozempic, and Saxenda.
Rybelsus is licensed for the treatment of Type 2 Diabetes in the UK under the authority of the Medicines and Healthcare products Regulatory Agency. Ozempic is the injectable version of Semaglutide for Type 2 Diabetes.
Tablets may suit people who:
Prefer not to use injections
Like taking medication as part of a daily routine
Don't mind taking medication before breakfast
Injections may suit people who:
Prefer once-weekly treatment
Want greater flexibility around meal timing
Are comfortable with self-injection
Your healthcare professional can help you decide which option best fits your lifestyle and weight loss goals.